Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series

January 10, 2022 updated by: Sylvestre KABURA

This is a retrospective study extending over a period of three years concerning patients with gastric adenocarcinoma hospitalized in the digestive cancer surgery and liver transplant service of the IBN ROCHD University Hospital Center in Casablanca. Evaluation from a series of 80 cases of gastric adenocarcinomas, follow-up to determine the prognostic factors influencing mortality, morbidity and survival.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Procedure: Total or subtotal gastrectomy

Study Type

Observational

Enrollment (Actual)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study enrolled all the patients who underwent gastric resection for gastric adenocarcinoma

Description

Inclusion Criteria:

patients with gastric cancer

Exclusion Criteria:

patients with benign tumors or other pathologies requiring gastric resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Overall survival Time Frame: 30 months	An overall survival of patients treated for gastric cancer	30 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sylvestre KABURA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

December 27, 2021

First Submitted That Met QC Criteria

January 10, 2022

First Posted (Actual)

January 11, 2022

Study Record Updates

Last Update Posted (Actual)